Majeed Nada, Bannan Badr, Ahmad Niaz, Zia Zergham, Ashour Majed
Departmet of Diagnostic and Interventional Radiology, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia.
Department of Surgery, Section of Transplantation and Hepatobiliary Surgery, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia.
BJR Case Rep. 2022 Nov 1;8(6):20220073. doi: 10.1259/bjrcr.20220073.
Portal venous aneurysms (PVAs) are a rare venous aneurysms. The mean diameter of a healthy portal vein varies considerably, with maximum diameter of 15 mm in healthy subjects and 19 mm in cirrhotic patients. The presentation varies; they could come with abdominal pain or more often as an incident imaging finding. Although risk factors like portal hypertension and liver cirrhosis have been highlighted, the aetiology remains to be clarified. PVA may be associated with various complications: thrombosis, aneurysmal rupture, inferior vena cava obstruction or duodenal compression. A conservative treatment showed satisfying clinical and radiological response, however, surgical and endovascular options can be considered. The aetiology and the mechanism of formation of PVA remain ill-defined. We aimed to use the small cohort of cases to define the distribution and radiological features of PVA and not for determining its prevalence or details of management. We retrospectively reviewed six cases from our institution (King Faisal Specialist Hospital and Research Centre, Jeddah) with variable presentations, complications and outcomes. Our review revealed that portal venous system aneurysms were mostly incidental, single, not gender- or age-specific and were frequently (66%) intrahepatic. Main portal vein was involved in three cases and splenic vein in only one case. Most of the portal venous system aneurysms were fusiform in configuration. Although PVAs are rare, more cases are detected through imaging. Hepatobiliary surgeons, gastroenterologists and radiologists should be aware of this entity, as it can have a wide variety of clinical spectrum. Our review and the limited evidence in published literature suggest that an individualised multidisciplinary team approach should be adopted to decide the best management and outcomes for each patient.
门静脉瘤(PVAs)是一种罕见的静脉瘤。健康门静脉的平均直径差异很大,健康受试者的最大直径为15毫米,肝硬化患者为19毫米。其表现各不相同;可能伴有腹痛,或更常见的是作为影像学检查偶然发现。尽管门静脉高压和肝硬化等危险因素已被强调,但其病因仍有待阐明。PVA可能与各种并发症相关:血栓形成、动脉瘤破裂、下腔静脉阻塞或十二指肠受压。保守治疗显示出令人满意的临床和影像学反应,然而,也可考虑手术和血管内治疗方案。PVA的病因和形成机制仍不明确。我们旨在利用这一小批病例来确定PVA的分布和影像学特征,而非确定其患病率或治疗细节。我们回顾性分析了我院(吉达法赫德国王专科医院和研究中心)6例表现、并发症及预后各异的病例。我们的回顾显示,门静脉系统动脉瘤大多为偶然发现,单个出现,无性别或年龄特异性,且常(66%)位于肝内。主要门静脉受累3例,脾静脉仅受累1例。门静脉系统动脉瘤大多呈梭形。尽管PVA很罕见,但通过影像学检查发现的病例越来越多。肝胆外科医生、胃肠病学家和放射科医生应了解这一疾病,因为它可能有广泛的临床谱。我们的回顾以及已发表文献中的有限证据表明,应采用个体化的多学科团队方法来为每位患者决定最佳治疗方案和预后。